Page last updated: 2024-12-11

du 86

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

DU 86: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9848462
CHEMBL ID35670
MeSH IDM0243011

Synonyms (6)

Synonym
CHEMBL35670
du-86
1,2,4,5,8,8a-hexahydro-6-methyl-4-oxo-2-((5,6,7-trimethoxy-1h-indol-2-yl)carbonyl)-cyclopropa(c)pyrrolo(3,2-e)indole-7-carboxylic acid methyl ester
du 86
153925-97-4
methyl (1r,12s)-4-methyl-7-oxo-10-(5,6,7-trimethoxy-1h-indole-2-carbonyl)-5,10-diazatetracyclo[7.4.0.01,12.02,6]trideca-2(6),3,8-triene-3-carboxylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID87725In vitro anticellular activity expressed as inhibitory concentration for the growth of HeLa S3 cells for a period of 72 hour1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
AID134326Hematotoxicity determined as number of peripheral platelets of normal mice on day 7 (percent of control)1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID87747In vitro inhibition of HeLa S3 cell growth by 50% after 1 hr.1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID116118In vivo antitumor activity (0.125 mg/Kg) is the measure of increase in life span of mice bearing P388 murine leukemia cells1999Journal of medicinal chemistry, Apr-22, Volume: 42, Issue:8
Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
AID87726In vitro anticellular activity expressed as inhibitory concentration for the growth of human uterine cervix carcinoma HeLa S3 cells for a period of 1 hour1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.
AID134791lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.20 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID134794lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.29 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID122153In vivo antitumor activity (0.5 mg/Kg) is the measure of tumor growth inhibition in mice bearing S180 murine sarcoma cells1999Journal of medicinal chemistry, Apr-22, Volume: 42, Issue:8
Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
AID134797lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.42 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID134796lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.35 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID150651In vitro concentration required to inhibit the growth of P338 murine leukemia cells by 50%1999Journal of medicinal chemistry, Apr-22, Volume: 42, Issue:8
Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
AID134790lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.17 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID140832Hematotoxicity determined as number of white blood cells of tumor-bearing mice on day 4 (percent of control).1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID87748In vitro inhibition HeLa S3 cell growth by 50% after 72 hr.1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID137065In vivo antitumor activity expressed as T/C in mice implanted subcutaneously (sc) with sarcoma180 tumor cells, and dose 0.25(mg/kg) administered intravenously1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID134798lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.50 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
AID134793lethal toxicity of compound was determined by calculating mortality in 10 ddY mice at the dose of 0.24 mg/kg1999Journal of medicinal chemistry, Jul-29, Volume: 42, Issue:15
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment-A of A-ring pyrrole compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (60.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.80 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]